88IV - PR Newswire Asia's news - Health Care/Hospital

< Previous page

| Title only | Print

Next page >

Servier and n-Lorem Foundation join forces to advance research in rare neurodevelopmental disorders Partnership will combine n-Lorem's cutting-edge antisense oligonucleotide (ASO) technology and Servier's R&D expertise with the aim of advancing ASO technology and delivering precision medicine ... 2026-06-10T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
Harbour BioMed Announces NMPA Acceptance of IND Application for HBM7004 for the Treatment of Advanced Solid Tumors CAMBRIDGE, Mass., ROTTERDAM, Netherlands and SHANGHAI , June 10, 2026 /PRNewswire/ -- Harbour BioMed (the "Company"; HKEX: 02142), a global biopharmaceutical company committed to the discovery ... 2026-06-10T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
Carestream Launches NEW Lux HD 35 and Lux HD 43 Detectors for Medical Imaging SHANGHAI , June 10, 2026 /PRNewswire/ -- Carestream announces the availability of its new generation of Cesium Iodide (CsI), glass-free X-ray Detector in markets all over the world, the Carestream Lux ... 2026-06-10T Computer/Electronics Consumer Electronics Health Care/Hospital
XtalPi Announces Strategic Partnership with a Leading Biopharma to Develop Oral Small Molecule Therapeutics for a GPCR Target BOSTON and SHENZHEN, China , June 10, 2026 /PRNewswire/ -- XtalPi (2228.HK), a leading platform in artificial intelligence (AI) and robotics-driven drug discovery, today announced a strategic partnership ... 2026-06-10T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
Antengene Receives IND Approval for ATG-201 (CD19 × CD3 TCE) in Autoimmune Disease in China SHANGHAI and HONG KONG , June 10, 2026 /PRNewswire/ -- Antengene Corporation Limited ( "Antengene" , SEHK: 6996.HK), a leading innovative, commercial-stage global biotech company dedicated ... 2026-06-10T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
Lynk Pharmaceuticals' Partner Formation Bio Doses First Participant in Phase 1 Trial of BLKR201 (originally designated as LNK01006), a CNS-Penetrant TYK2 Inhibitor HANGZHOU, China, SHANGHAI and BOSTON , June 10, 2026 /PRNewswire/ -- Lynk Pharmaceuticals Co., Ltd. ("Lynk Pharmaceuticals"), a clinical-stage innovative drug development company focused on ... 2026-06-10T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
Huawei Launches the "AHEAD" Program to Build a New Ecosystem for Mutual Benefits in Education and Healthcare SHENZHEN, China , June 9, 2026 /PRNewswire/ -- The 2026 Global Education & Healthcare Partners Convention, convened under the theme "Together, Enabling Intelligent-led Education & Healthcare," ... 2026-06-09T Computer/Electronics Education Health Care/Hospital Internet Technology
First Patients Dosed in Phase 2 SIRIUS COPD Study of HBM9378/WIN378, a Fully Human Ultra Long-Acting Anti-TSLP Antibody COPD study initiation expands HBM9378/WIN378 (also known as SKB378) development into a second major respiratory disease HBM9378/WIN378 is currently being evaluated in the Phase 2/3 POLARIS asthma ... 2026-06-09T Health Care/Hospital Medical/Pharmaceuticals
Kelun-Biotech Partner Windward Bio Announces First Patients Dosed in Phase 2 SIRIUS COPD Study of SKB378/WIN378 COPD study initiation expands SKB378/WIN378 development into a second major respiratory disease SKB378/WIN378 is currently being evaluated in the Phase 2/3 POLARIS asthma study, with initial Phase ... 2026-06-09T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
SK bioscience Joins Forces with Global Institutions to Advance Rotavirus Vaccine Development SK bioscience licenses vaccine technology from the U.S. Centers for Disease Control and Prevention SK bioscience is jointly investing with the RIGHT Foundation to drive process development that enhances ... 2026-06-09T Biotechnology Health Care/Hospital Infectious Disease Control Medical/Pharmaceuticals

< Previous page

Next page >

88iv | Home | Login

Forum rule | About Us | Contact Info | Terms & Conditions | Privacy Statment | Disclaimer

Copyright (C) 2026

Suntek Computer Systems Limited.

All rights reserved